Iktos announces a collaboration deal with Galapagos, a leading global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines, to apply Iktos’s generative modeling artificial intelligence (AI) technology in one of Galapagos’s drug discovery programs. Follow the link for the full press release.
